Dorgan Byron L

Avg. Two Year Performance

No purchase track record
< 1% Avg. Sale Return
0% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)6%3%(2%)< 1%
Sale Success Rate2 of 63 of 62 of 60 of 61 of 6

Codexis, Inc.

Drugs » Biotechnology

Director:

Holdings: 223.58K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--